Extracorporeal Photopheresis—An Overview
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988. After the first positive experiences with CTCL, additional indications have been su...
| Published in: | Frontiers in Medicine |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2018-08-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00236/full |